UPI: FDA grants approval to Eli Lilly for alopecia drug

  • Matthew Harries

Press/Media: Expert comment

Period13 Jun 2022

Media contributions

1

Media contributions

  • TitleFDA grants approval to Eli Lilly for alopecia drug
    Media name/outletUPI
    Media typeWeb
    Country/TerritoryUnited States
    Date13/06/22
    DescriptionDr. Andrew Messenger of the University of Sheffield and Matthew Harries of the University of Manchester wrote in an accompanying editorial that the Eli Lilly trial results "are impressive" and the findings represent "the first published phase 3 trials of any treatment for this condition."
    URLhttps://www.upi.com/Health_News/2022/06/13/FDA-grants-approval-Eli-Lilly-alopecia-drug/2981655158725/
    PersonsMatthew Harries

Keywords

  • alopecia